Price $1.52 |
Market Cap
166.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.57
|
P/S
16.12
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-35K
|
FCF
-0.3
|
|
Op. Margin
-814.20%
|
Net Margin
-842.30%
|
ROE
-71.50%
|
ROI
-78.10%
|
|
ROA
-51.80%
|
EPS Growth
40.30%
|
Current Ratio
2.3
|
Debt/Equity
1.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Advanz Pharma Corp Ltd (CXRXF) | $16.80 | - | - | 826.6M | Strong Buy |
| AEterna Zentaris Inc. (USA) (AEZS) | $0.95 | - | - | 131.2M | Strong Buy |
| Cannapharmarx Inc (CPMD) | $0.17 | - | - | 10M | Strong Buy |
| AmerisourceBergen Corp. (ABC) | $117.63 | - | 1.50% | 24.82B | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $0.94 | - | - | 106.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
